Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients.

Inagaki M, Akechi T, Okuyama T, Sugawara Y, Kinoshita H, Shima Y, Terao K, Mitsunaga S, Ochiai A, Uchitomi Y.

Support Care Cancer. 2013 Aug;21(8):2097-106. doi: 10.1007/s00520-013-1767-x. Epub 2013 Feb 28.

PMID:
23446881
2.

Plasma interleukin-6 and fatigue in terminally ill cancer patients.

Inagaki M, Isono M, Okuyama T, Sugawara Y, Akechi T, Akizuki N, Fujimori M, Mizuno M, Shima Y, Kinoshita H, Uchitomi Y.

J Pain Symptom Manage. 2008 Feb;35(2):153-61. Epub 2007 Dec 21.

PMID:
18082358
3.

Depressed patients with incurable cancer: which depressive symptoms do they experience?

Brenne E, Loge JH, Kaasa S, Heitzer E, Knudsen AK, Wasteson E; European Palliative Care Research Collaborative (EPCRC).

Palliat Support Care. 2013 Dec;11(6):491-501. doi: 10.1017/S1478951512000909. Epub 2013 Feb 7. Erratum in: Palliat Support Care. 2013 Dec;11(6):535.

PMID:
23388067
4.

Factors correlated with fatigue in terminally ill cancer patients: a longitudinal study.

Okuyama T, Akechi T, Shima Y, Sugahara Y, Okamura H, Hosaka T, Furukawa TA, Uchitomi Y.

J Pain Symptom Manage. 2008 May;35(5):515-23. doi: 10.1016/j.jpainsymman.2007.06.014. Epub 2008 Mar 4.

PMID:
18294810
5.

Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients: associated and predictive factors.

Akechi T, Okuyama T, Sugawara Y, Nakano T, Shima Y, Uchitomi Y.

J Clin Oncol. 2004 May 15;22(10):1957-65.

PMID:
15143090
6.

The relationship between interleukin-6, tumor necrosis factor-α, and fatigue in terminally ill cancer patients.

Kwak SM, Choi YS, Yoon HM, Kim DG, Song SH, Lee YJ, Yeom CH, Koh SJ, Park J, Lee MA, Suh SY.

Palliat Med. 2012 Apr;26(3):275-82. doi: 10.1177/0269216311406991. Epub 2011 Aug 1.

PMID:
21807751
7.

Fatigue is associated with serum interleukin-6 levels and symptoms of depression in patients on chronic hemodialysis.

Bossola M, Di Stasio E, Giungi S, Rosa F, Tazza L.

J Pain Symptom Manage. 2015 Mar;49(3):578-85. doi: 10.1016/j.jpainsymman.2014.07.009. Epub 2014 Aug 15.

PMID:
25135658
8.

Relations between desire for early death, depressive symptoms and antidepressant prescribing in terminally ill patients with cancer.

Tiernan E, Casey P, O'Boyle C, Birkbeck G, Mangan M, O'Siorain L, Kearney M.

J R Soc Med. 2002 Aug;95(8):386-90.

9.

Serum levels of interleukin-6 and interleukin-10 in relation to depression scores in patients with cardiovascular risk factors.

Meyer T, Stanske B, Kochen MM, Cordes A, Yüksel I, Wachter R, Lüers C, Scherer M, Binder L, Pieske B, Herrmann-Lingen C.

Behav Med. 2011 Jul;37(3):105-12. doi: 10.1080/08964289.2011.609192.

PMID:
21895428
10.

Factors associated with the wish to hasten death: a study of patients with terminal illness.

Kelly B, Burnett P, Pelusi D, Badger S, Varghese F, Robertson M.

Psychol Med. 2003 Jan;33(1):75-81.

PMID:
12537038
11.

Course and predictors of depressive symptoms among family caregivers of terminally ill cancer patients until their death.

Tang ST, Chang WC, Chen JS, Wang HM, Shen WC, Li CY, Liao YC.

Psychooncology. 2013 Jun;22(6):1312-8. doi: 10.1002/pon.3141. Epub 2012 Jul 27.

PMID:
22836818
12.

Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings.

Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, Pearce BD, Landry J, Glover S, McDaniel JS, Nemeroff CB.

Am J Psychiatry. 2001 Aug;158(8):1252-7.

PMID:
11481159
13.

Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer.

Geinitz H, Zimmermann FB, Stoll P, Thamm R, Kaffenberger W, Ansorg K, Keller M, Busch R, van Beuningen D, Molls M.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):691-8.

PMID:
11597810
14.

Systematic monitoring and treatment of physical symptoms to alleviate fatigue in patients with advanced cancer: a randomized controlled trial.

de Raaf PJ, de Klerk C, Timman R, Busschbach JJ, Oldenmenger WH, van der Rijt CC.

J Clin Oncol. 2013 Feb 20;31(6):716-23. doi: 10.1200/JCO.2012.44.4216. Epub 2013 Jan 2.

PMID:
23284036
15.

Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes.

Wichers MC, Koek GH, Robaeys G, Praamstra AJ, Maes M.

Psychol Med. 2005 Mar;35(3):433-41.

PMID:
15841878
16.

Depression and generalized anxiety symptoms in panic disorder. Implications for comorbidity.

Ball SG, Buchwald AM, Waddell MT, Shekhar A.

J Nerv Ment Dis. 1995 May;183(5):304-8.

PMID:
7745384
17.
18.

Depression, cytokines, and pancreatic cancer.

Breitbart W, Rosenfeld B, Tobias K, Pessin H, Ku GY, Yuan J, Wolchok J.

Psychooncology. 2014 Mar;23(3):339-45. doi: 10.1002/pon.3422. Epub 2013 Oct 18.

19.

Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale.

Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K.

J Pain Symptom Manage. 2003 May;25(5):420-9.

PMID:
12727039
20.

What do predict anxiety and depression in breast cancer patients? A follow-up study.

Vahdaninia M, Omidvari S, Montazeri A.

Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):355-61. doi: 10.1007/s00127-009-0068-7. Epub 2009 May 21.

PMID:
19458878

Supplemental Content

Support Center